Edition:
India

Roche Holding AG (RHHBY.PK)

RHHBY.PK on OTC Markets Group

35.13USD
12:54am IST
Change (% chg)

$0.69 (+2.00%)
Prev Close
$34.44
Open
$34.91
Day's High
$35.23
Day's Low
$34.86
Volume
392,833
Avg. Vol
1,051,918
52-wk High
$35.90
52-wk Low
$25.10

Summary

Name Age Since Current Position

Severin Schwan

52 2013 Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director

Christoph Franz

59 2011 Non-Executive Independent Chairman of the Board

Fritz Gerber

89 2004 Honorary Chairman of the Board

Andre Hoffmann

61 Non-Executive Independent Vice Chairman of the Board

Alan Hippe

52 2011 Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer

Cristina Wilbur

52 2016 Member of the Corporate Executive Committee, Head Group Human Resources

Urs Jaisli

63 Chief Compliance Officer

Gottlieb Keller

65 2008 Member of the Corporate Executive Committee, General Counsel, Secretary to the Board of Directors

William Anderson

52 2019 Member of the Corporate Executive Committee, Chief Executive Officer Roche Pharmaceuticals

Stephan Feldhaus

57 2010 Member of the Enlarged Corporate Executive Committee, Head Group Communications

William Pao

52 2018 Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research & Early Development (pRED)

James Sabry

60 2018 Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering

Thomas Schinecker

44 2019 Member of the Corporate Executive Committee, Chief Executive Officer Roche Diagnostics

Michael Varney

61 2015 Member of the Enlarged Corporate Executive Committee, Head Genentech Research & Early Development (gRED)

Per-Olof Attinger

59 2010 Secretary to the Corporate Executive Committee

John Bell

66 2001 Non-Executive Independent Director

Julie Brown

57 2016 Non-Executive Independent Director

Paul Bulcke

65 2011 Non-Executive Independent Director

Anita Hauser

50 2017 Non-Executive Independent Director

Richard Lifton

66 2015 Non-Executive Independent Director

Andreas Oeri

69 1996 Non-Executive Independent Director

Bernard Poussot

67 2015 Non-Executive Independent Director

Claudia Suessmuth Dyckerhoff

52 2016 Non-Executive Independent Director

Karl Mahler

Head of Investor Relations

Biographies

Name Description

Severin Schwan

Dr. Severin Schwan has been Chairman of the Corporate Executive Committee, Chief Executive Officer and Executive Director of Roche Holding Ltd since 2013. He was Chairman of the Corporate Executive Committee and Chief Executive Officer of Roche Holding AG from March 4, 2008. He was previously Chief Executive Officer of the Division Roche Diagnostics and Member of the Corporate Executive Committee at the Company from January 1, 2006. Between 1993 and 1995, he was a Trainee at Corporate Finance for Roche Basel. From 1995 until 1998, he was Head of Finance & Administration at Roche Brussels. From 1998 until 2000, Dr. Schwan was Head Finance & Informatics at Roche Grenzach, Germany and Member of the Executive Board of Roche Deutschland Holding GmbH. From 2000 until 2004, he was Head of Global Finance & Services at Roche Diagnostics, Basel. Since 2009, Dr. Schwan has been Member of the Board of Directors of Chugai Pharmaceuticals, Japan, and Member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC). Dr. Schwan studied Economics at Universitaet Innsbruck, University of York and University of Oxford. He gained an Economics Degree from Innsbruck. He studied Law at Universitaet Innsbruck and gained a Law degree in 1991. Dr. Schwan then completed a Doctorate in Law at Universitaet Innsbruck in 1993 and Research studies at Universite Catholiques de Louvaine, Belgium.

Christoph Franz

Dr. Christoph Franz has been Non-Executive Independent Chairman of the Board of Roche Holding Ltd since March 1, 2011. He is Member of the Remuneration Committee and Chairman of the Presidium/Nomination Committee at the Company. He began his career in 1991 with Deutsche Lufthansa AG. In 1994 he joined Deutsche Bahn AG and acted as Member of the Executive Board and CEO of passenger transport division. In 2004 he became Chief Executive Officer of Swiss International Air Lines AG. In 2009 Dr. Franz became Member of the Executive Board of Deutsche Lufthansa AG and Deputy to the Executive Board Chairman and CEO Lufthansa Passenger Airlines. Since January 2011 he has been Chairman of the Executive Board and Chief Executive Officer of Deutsche Lufthansa AG. He holds a Doctorate degree (Dr. rer. pol.) from Technische Universitaet Darmstadt (Darmstadt University of Technology).

Fritz Gerber

Dr. Fritz Gerber has served as Honorary Chairman of the Board at Roche Holding AG since 2004. Between 2001 and 2004, he additionally acted as Company's Member of the Board of Directors. From 1978 to 1997 Dr. Gerber occupied the position of Chairman of the Board at Roche Holding Ltd. and was also active as Chief Executive Officer between 1978 and 1997. Dr. Gerber has worked in the Federal Department of Economic Affairs, Bern (now SECO). In 1958, he joined "Zuerich" Insurance Company (now Zurich Financial Services), where he became General Manager in 1969 and Chairman of the Management Board in 1974. From 1977 until 1991, Dr. Gerber was Chairman of the Board of Directors and Chief Executive Officer and from 1991 until 1995, he was Non-Executive Chairman of the Board of Directors. Since 1995, he has been Honorary Chairman of Zurich Financial Services. From 1978 until 1997, he was Chairman of the Board of Directors and Chief Executive Officer of F. Hoffmann-La Roche & Co. Ltd. (now: Roche Holding Ltd.). From 1978 until 2001, Dr. Gerber was Chairman of the Board of Directors and from 2001 until 2004, he was Member of the Board of Directors and Honorary Chairman. He has also served as Member of the Board of I.C.I. Switzerland from 1967 until 1991, Alusuisse, Zuerich from 1977 until 1981, Credit Suisse, Zuerich, from 1978 until 1996, Nestle, Vevey (Deputy Chairman of the Board) from 1981 until 2001, IBM Corporation, Armonk from 1989 until 1996 and Bank Sal. Oppenheim jr., Zurich from 1997 until 2005. He served as Chairman of the Paul Sacher Foundation for contemporary music until April 2006, was Member of the Executive Committee of the Lucerne Music Festival until 2004 and Member of the Orchesterakademie des Philharmonischen Orchesters Berlin until 2004. Dr. Gerber has been Honorary Chairman of the Fritz Gerber Foundation. He studied at Universitaet Bern and graduated as Lawyer (LL.M) and was admitted to the bar. He is an Honorary Doctor of Natural Science of Universitaet Basel, Switzerland.

Andre Hoffmann

Mr. Andre S. Hoffmann serves as Non-Executive Independent Vice Chairman of the Board at Roche Holding Ltd. He is representative of the shareholder group with pooled voting rights. He also acts as Member of the Presidium/Nomination Committee, Corporate Governance and Sustainability Committee, as well as Chairman of the Remuneration Committee of the Company. He joined the Company’s Board of Directors in 1996. From 1977 until 1978, he studied at Universite de Geneve and from 1979 until 1982 he studied at St. Gallen School. In 1990, he received a Master of Business Administration degree from Institut Europeen d’Administration des Affaires (INSEAD). From 1985 until 1989, he worked for James Capel and Co., where his latest position was Manager, European Mergers & Acquisitions. From 1991 until 1993, he worked for Nestle UK Ltd., where his latest position was Special Project Manager, Food division. Since 1994, he worked in Private Investment Activities. Since 2000, he has been Member of the Board of Givaudan Ltd., Member of the Board of Glyndebourne Productions Ltd., and Chairman of Nemadi Advisors Ltd. Since 2003, he has been Member of the Board of Brunswick Capital Ltd. and Chairman of Living Planet Fund Management Co. He has served as Vice President of WWF International, Treasurer of Fondation les Corbillettes pour l'Aide aux enfants handicapes mentaux, Member of the Executive Committee of IRP, Institut International de Recherche en Paraplegie, Founding Member of Stiftung Patronatskomitee Kunstmuseum Basel, Board Member of Roche Research Foundation, International Council Member of Tate Gallery, Chairman of the Board of Fondation Pro Valat, Vice Chairman of the Board of Fondation Sansouire, Board Member of Takh, Association pour le Cheval de Przewalski, President of FIBA, Fondation Internationale du Banc d'Arguin, among others.

Alan Hippe

Dr. Alan Hippe has been Member of the Corporate Executive Committee, Chief Financial Officer and Information Technology Officer at Roche Holding Ltd since April 1, 2011. Between 1993 and 1996 Dr. Hippe was Research Assistant and Teaching Assistant at the Universities of Mainz and Mannheim. In 1996 he joined AVECO Holding AG as Head of group controlling and IT systems. He served as Member of the Executive Board of Continental AG from 2002 to 2009. In April 2009 he was appointed Chief Financial Officer and Member of Executive Board of ThyssenKrupp AG.

Cristina Wilbur

Ms. Cristina A. Wilbur has been Member of the Corporate Executive Committee, Head Group Human Resources of Roche Holding Ltd since March 2016. She holds Bachelor of Science degree in Accounting from California Polytechnic University. She served at EG&G as Human Resources and Payroll Manager and later as Human Resources Director. In 2001 she joined PerkinElmer Optoelectronics as Human Resources Director. In 2002 she joined Roche Diagnostics Corporation as Human Resources Director, where in 2006 she was appointed Vice-President, North America Region Human Resources and Communications. In 2010 she became Senior Vice-President and Global Head of Human Resources at Roche Diagnostics Division. She has been Chair of the Board of Directors at International School Basel Reinach AG.

Urs Jaisli

Gottlieb Keller

Dr. Gottlieb A. Keller has been Member of the Corporate Executive Committee, General Counsel, Secretary to the Board of Directors at Roche Holding Ltd since March 5, 2008. He was previously Head of Human Resources and Corporate Services, as well as Secretary to the Board of Directors and Member of Corporate Executive Committee at the Company as of 2004. In 1984, he joined the Corporate Law Department of the Roche Group. In 1989, he became Head of Business Development and Pharma Marketing Services of Roche Grenzach, Germany. In 1992, he became Assistant to the Chairman of the Board of Directors of Roche Holding Ltd. In 1996, he became Head of Human Resources at Hoffmann-La Roche Ltd, Germany. In 1998, he became Speaker of the Management Board of Hoffmann-La Roche Ltd, Germany. In 1999, he became Chairman of the Executive Board of Roche Deutschland Holding GmbH and then Secretary to the Board of Directors of Roche Holding Ltd and Corporate Compliance Officer of the Roche Group. In 2003, he became Member of the Corporate Executive Committee of the Roche Group and Head of Corporate Human Resources and Pharma Site Management in Basel and Kaiseraugst. In 2004, he became Head of Corporate Services and Human Resources. He has been Committee Member of VSUD, President of the Board of Crocodil AG, Member of the Chairman's Committee of the Chamber of Commerce Germany-Switzerland, Member of the Board of Trustees of the Fritz Gerber Foundation for talented young people, Member of the Board of Trustees of the Paul Sacher Foundation and of swisscontact and Board Member of SGCI Chemie Pharma Schweiz and of economiesuisse. From 2003 until 2008, he was Board Member of the Basilea Pharmaceutica AG. Dr. Keller studied Law and Economics at Universitaet Basel and gained a Doctor of Law (Dr. iur) in 1980. He was admitted as Attorney in 1981 and became Notary Public of Basel in 1984 (not practicing).

William Anderson

Mr. William N. (Bill) Anderson has been Member of the Corporate Executive Committee, Chief Executive Officer Roche Pharmaceuticals at Roche Holding Ltd since January 1, 2019. He is former Chief Executive Officer of Genentech.

Stephan Feldhaus

Dr. Stephan Feldhaus is no longer a Member of the Enlarged Corporate Executive Committee, Head Group Communications at Roche Holding Ltd effective September 30th, 2019. He studied Roman Catholic Theology and Philosophy at Roman University of Muenster, Universitaet Zuerich and Lucerne and Ludwig-Maximilians-Universitaet Muenchen (University of Munich) and obtained his Doctorate in Theology (Dr. theol.) at the University of Munich in 1997. He started his career at Ludwig-Maximilians-Universitaet Muenchen (the University of Munich) as Scientific Assistant in 1989. He than worked for Cusanus Werk (Academic Foundation of the German bishops) as Scientific Assistant and Editor. In 1999, he joined Siemens AG.

William Pao

Dr. William Pao has been Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research & Early Development (pRED) at Roche Holding Ltd since April 2, 2018. He is former Global Head of the Oncology Discovery and Translational Area for pRED.

James Sabry

Dr. James H. Sabry, M.D., Ph.D., has been Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding Ltd since August 1, 2018. He is former global Head Genentech Partnering.

Thomas Schinecker

Mr. Thomas Schinecker has been appointed as Member of the Corporate Executive Committee, Chief Executive Officer Roche Diagnostics of the Company with effect from 1 August 2019. He began his career in 2003 as a trainee for Roche Diagnostics under the Roche Perspectives programme. He has held various management positions in marketing & sales and product development in Singapore, Austria, Sweden and the United States. Before assuming his current position as Head of the Global Business Area Centralised and Point of Care Solutions based in Rotkreuz, Switzerland, he was General Manager for Roche Diagnostics Germany. Thomas Schinecker holds a PhD in Molecular Biology from New York University, USA.

Michael Varney

Dr. Michael David Varney, Ph.D., has been Member of the Enlarged Corporate Executive Committee, Head Genentech Research & Early Development (gRED) at Roche Holding Ltd since 2015. He holds Bachelor of Science degree form University of California, Los Angeles (Chemistry, 1980) and a Ph.D. from California Institute of Technology (Organic Synthesis, 1985). From 1985 to 1987 he was Postdoctoral Research Fellow at the Columbia University. In 1987 he joined Agouron Pharmaceuticals Inc., where he served until 2000 and held such positions as Research Chemist, Director Medicinal Chemistry, Senior Director of Chemistry, Senior Director of Drug Discovery, Vice President and Head of Research as well as US, Corporate Vice President, Head of Research. From 2000 to 2005 he served at Pfizer Global R&D as Vice President, Drug Discovery. In 2005 he joined Genentech Inc., where he acted as Vice President of Small Molecule Drug Discovery, Senior Vice President, Research of Small Molecule Drug Discovery and Senior Vice President, Co-Head of Research and Head Small Molecule Discovery.

Per-Olof Attinger

Mr. Per-Olof Attinger has been Secretary to the Corporate Executive Committee at Roche Holding Ltd since August 1, 2010. Mr. Attinger started his professional career in 1986 at Sandoz as Engineer responsible for Chemical Process Development. He has served at Roche since 1992, where he has occupied various managerial positons, including Manager of Mergers & Acquisitions, among others. In 1984, he obtained a degree in Chemical Engineering from the Federal Institute of Technology (ETH) Zurich. He than made Thesis at Imperial College in London and received his Masters degree in Busines Administration from European Institute for Business Administration (INSEAD) in 1992.

John Bell

Prof. John Irving Bell has served as Non-Executive Independent Director of Roche Holding Ltd since 2001. In addition, he acts as Member of the Audit Committee of the Company. In 1975, he gained a Bachelor of Medical Science with Honors from the University of Alberta. In 1976, Prof. Sir Bell gained a Bachelor of Arts with Honors in Physiological Sciences from Magdalen College, Oxford University. In 1979, he gained a Bachelor of Medicine and Bachelor of Surgery (BM, BCh) from Magdalen College, Oxford University. In 1990, he gained a Doctor of Medicine (DM) from Magdalen College, Oxford University. From 1979 until 1982, he carried out postgraduate clinical training in Oxford and London. From 1982 until 1987, Prof. Sir Bell was Clinical Fellow in the Department of Medicine at Stanford University and also Postdoctoral Fellow in the Department of Medical Microbiology at Stanford University. From 1987 until 1989, he was Wellcome Senior Clinical Fellow and Honorary Consultant Physician in the Nuffield Departments of Clinical Medicine and Surgery at John Radcliffe Hospital, Oxford. From 1989 until 1992, he was University Lecturer at the Nuffield Department of Clinical Medicine at Oxford University. From 1992 until 2002, he was Nuffield Professor of Clinical Medicine at Oxford University. Since 2002, Prof. Bell has been Regius Professor of Medicine at Oxford University. He has also been Honorary Consultant Physician at Oxford Radcliffe NHS Trust since 1987; Nuffield Professor of Clinical Medicine Chairman at the Department of Medicine, Oxford University School of Medicine, since 1992; Founder of the Wellcome Trust Centre for Human Genetics since 1993; Chairman of the Partnership Board at the Oxford Centre for Diabetes, Endocrinology and Metabolism since 1999; Chairman of the Trials and Epidemiology Building, Oxford since 1999; and President of the Academy of Medical Sciences since 2006. He was knighted in the 2008 Honors list for Services to Medicine.

Julie Brown

Ms. Julie Brown has served as Non-Executive Independent Director of Roche Holding Ltd since March 1, 2016. She is Chairman of the Audit Committee at the Company.

Paul Bulcke

Mr. Paul Bulcke has served as Non-Executive Independent Director at Roche Holding Ltd since March 1, 2011. He is Member of the Audit Committee at the Company. He started his career in 1977 as Financial Analyst with Scott Graphics International. In 1979 he joined Nestle Group where he held several position including Marketing trainee, sales and division functions, Market Head at Nestle Portugal, Nestle Chech and Slovak Republic, as well as at Nestle Germany. Between 2004 and 2008, Mr. Bulcke acted as Executive Vice President, Nestle S.A. as well as Zone Director for Zone Americas: United States of America, Canada, Latin America and Caribbean. Mr. Bulcke has been Chief Executive Officer of Nestle S.A. since April 2008. He studied Commercial Engineering at Katholieke Universiteit Leuven, from which he graduated in 1976. Between 1976 and 1977 he attended postgraduate studies in Management at Vlerick Leuven Gent Management School (Universiteit Gent), and in 1995 he completed Program for Executive Development at Institute of Management Development (IMD) Switzerland.

Anita Hauser

Ms. Anita Hauser has been Non-Executive Independent Director of Roche Holding Ltd since March 14, 2017. She is Member of the Corporate Governance and Sustainability Committee at the Company.

Richard Lifton

Prof. Dr. Richard P. Lifton has served as Non-Executive Independent Director at Roche Holding Ltd since 2015. He is Member of the Remuneration Committee at the Company.

Andreas Oeri

Dr. Andreas Oeri, M.D., has served as Non-Executive Independent Director at Roche Holding Ltd since 1996. He is a representative of the shareholder group with pooled voting rights. In addition, he acts as Chairman of the Corporate Governance and Sustainability Committee of the Company. From 1997 until 1985, he worked as Assistant Physician in the Surgical Clinic of the Cantonal Hospital (Kantonsspital) in Liestal, the Institute for Physical Medicine of the Cantonal Hospital (Kantonsspital) in Basel, the Surgical Department of the University of Basel and Basel University Orthopedic Hospital. From 1986 until 1988, Dr. Oeri was Acting Senior Physician of the Basel University Orthopedic Hospital. In 1988 he became a Specialist in Orthopedic Surgery (FMH). Since 1988, he has had his own practice for Orthopedic Surgery in Basel. Dr. Oeri completed Medical Studies at Universitaet Basel and holds a Swiss Medical Diploma as well as a Doctorate of Medicine.

Bernard Poussot

Mr. Bernard J. Poussot has served as Non-Executive Independent Director of Roche Holding Ltd since 2015. He is Member of the Remuneration Committee at the Company.

Claudia Suessmuth Dyckerhoff

Dr. Claudia Suessmuth Dyckerhoff has served as Non-Executive Independent Director of Roche Holding Ltd since March 1, 2016. She is Member of the Corporate Governance and Sustainability Committee and the Audit Committee at the Company.

Karl Mahler